[Adverse reaction of LH-RH agonist and its countermeasure].
Oishi
K
K
Division of Life Science, Graduate School of Integrated Science and Art, University of East Asia.
D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists*; D017273:Goserelin / Q000009:adverse effects*; D006801:Humans; D016729:Leuprolide / Q000009:adverse effects*; D007989:Libido / Q000187:drug effects; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D013375:Substance Withdrawal Syndrome / Q000209:etiology
D018931:Antineoplastic Agents, Hormonal; D017273:Goserelin; D007987:Gonadotropin-Releasing Hormone; D016729:Leuprolide